Transfusion Medicine and Hemotherapy
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 2.1 | Q3 | 41.7% | 0.671 | Q2 | 71.4% |
| 2024 | 1.9 | Q3 | 38.4% | 0.537 | Q3 | 64.7% |
| 2023 | 1.9 | Q4 | 19.4% | 0.582 | Q2 | 69.9% |
| 2022 | 2.2 | Q4 | 20.8% | 0.814 | Q2 | 81.0% |
| 2021 | 4.0 | Q3 | 43.8% | 0.957 | Q2 | 85.6% |
| 2020 | — | — | 0.971 | Q2 | 84.7% | |
| 2019 | — | — | 0.940 | Q2 | 84.3% | |
| 2018 | — | — | 0.737 | Q2 | 76.4% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1660-3796
ISSN
1660-3818
country
CHcoverage
1973, 1975-1997, 2003-2026